|
PHIP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.156000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.502600E-03 |
| Normal-vs-Stage2 |
2.429000E-04 |
| Normal-vs-Stage3 |
2.021600E-04 |
| Normal-vs-Stage4 |
1.297810E-03 |
| Stage1-vs-Stage2 |
3.638300E-02 |
| Stage1-vs-Stage3 |
1.437230E-01 |
| Stage1-vs-Stage4 |
2.574600E-01 |
| Stage2-vs-Stage3 |
3.090000E-01 |
| Stage2-vs-Stage4 |
4.076400E-01 |
| Stage3-vs-Stage4 |
9.692000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.742430E-03 |
| Normal-vs-AfricanAmerican |
1.266020E-01 |
| Normal-vs-Asian |
2.333600E-02 |
| Caucasian-vs-AfricanAmerican |
6.043000E-01 |
| Caucasian-vs-Asian |
7.023400E-01 |
| AfricanAmerican-vs-Asian |
8.249000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.587600E-04 |
| Normal-vs-Female |
1.202950E-03 |
| Male-vs-Female |
9.793000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.440290E-02 |
| Normal-vs-Age(41-60Yrs) |
3.564200E-04 |
| Normal-vs-Age(61-80Yrs) |
8.169100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.078060E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.398000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.065600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.078800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.856800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.709600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.810200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.329240E-01 |
| Classical-VS-Follicular |
5.70039999980843E-07 |
| Classical-VS-Other |
7.322400E-01 |
| Classical-VS-Normal |
3.019600E-02 |
| Tall-VS-Follicular |
1.239380E-01 |
| Tall-VS-Other |
6.640800E-01 |
| Tall-VS-Normal |
5.199000E-03 |
| Follicular-VS-Other |
2.364800E-01 |
| Follicular-VS-Normal |
5.63439999989868E-07 |
| Other-VS-Normal |
2.523000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.58019999999937E-05 |
| Normal-vs-N1 |
3.335700E-02 |
| N0-vs-N1 |
1.239190E-01 |
|
|
